Imatinib mesylate / Gleevec (CAS 220127-57-1) Market Research Report 2016

Date: December 1, 2016
Pages: 70
Price:
US$ 2,650.00 US$ 2,200.00 (This month only)
License [?]:
Publisher: BAC Reports
Report type: Strategic Report
Delivery: E-mail Delivery - PDF (on default),
Hard Copy Mail Delivery (+US$ 190.00)
ID: IA5A4F09349EN
Leaflet:

Download PDF Leaflet

Imatinib mesylate / Gleevec (CAS 220127-57-1) Market Research Report 2016

The report generally describes imatinib mesylate / gleevec, examines its uses, production methods, patents. Imatinib mesylate / Gleevec market situation is overviewed; imatinib mesylate / gleevec manufacturers and suppliers with contacts and product range are mentioned in the study.

Furthermore, imatinib mesylate / gleevec prices in regional markets can be found in the report with regards to countries and companies.

The report also focuses on imatinib mesylate / gleevec consumers by providing data on companies that use it.

BAC experts can supply with valuable information on the following positions for each chemical product in any country or region:

  • current market situation
  • capacity and production volumes
  • consumption volume and structure
  • export and import
  • market prices trends
  • existing technologies an patents
  • feedstock analysis
  • market forecast
  • etc.
Thus, Imatinib mesylate / Gleevec (CAS 220127-57-1) Market Research Report 2016 can feature:
  • imatinib mesylate / gleevec ranges, trademarks, analogous products, application areas, manufacturing methods
  • present imatinib mesylate / gleevec market conditions, prices
  • imatinib mesylate / gleevec market forecast, estimations
  • imatinib mesylate / gleevec manufacturers, consumers and traders (including contact details)

Imatinib mesylate / Gleevec (CAS 220127-57-1) Market Research Report 2016 contents were worked out and placed on the website in December, 2016. As a special offer the report price was brought down and now is as low as US$ 2,200.00. Do not lose the chance to order this Market Report for almost half-price.

1. IMATINIB MESYLATE / GLEEVEC (CAS 220127-57-1)

1.1. General information, synonyms
1.2. Composition, chemical structure
1.3. Safety information
1.4. Hazards identification
1.5. Handling and storage
1.6. Toxicological & ecological information
1.7. Transport information

2. IMATINIB MESYLATE / GLEEVEC APPLICATIONS

2.1. Imatinib mesylate / gleevec application spheres, downstream products

3. IMATINIB MESYLATE / GLEEVEC MANUFACTURING METHODS

4. IMATINIB MESYLATE / GLEEVEC PATENTS

Abstract
Description
Summary of the invention
Detailed description of the invention

5. IMATINIB MESYLATE / GLEEVEC MARKET WORLDWIDE

5.1. General imatinib mesylate / gleevec market situation, trends
5.2. Manufacturers of imatinib mesylate / gleevec
  - Europe
  - Asia
  - North America
  - Other regions
5.3. Imatinib mesylate / gleevec suppliers (importers, local distributors)
  - Europe
  - Asia
  - North America
  - Other regions
5.4. Imatinib mesylate / gleevec market forecast

6. IMATINIB MESYLATE / GLEEVEC MARKET PRICES

6.1. Imatinib mesylate / gleevec prices in Europe
6.2. Imatinib mesylate / gleevec prices in Asia
6.3. Imatinib mesylate / gleevec prices in North America
6.4. Imatinib mesylate / gleevec prices in other regions

7. IMATINIB MESYLATE / GLEEVEC END-USE SECTOR

7.1. Imatinib mesylate / gleevec market by application sphere
7.2. Imatinib mesylate / gleevec downstream markets trends and prospects
7.3. Imatinib mesylate / gleevec consumers globally
  - Europe
  - Asia
  - North America
  - Other regions

*Please note that Imatinib mesylate / Gleevec (CAS 220127-57-1) Market Research Report 2016 is a half ready publication and contents are subject to change. It only requires updating with the help of new data that are constantly retrieved from Publisher’s databases and other sources. This updating process takes 3-5 business days after order is placed. Thus, our clients always obtain a revised and updated version of each report. Please also note that we do not charge for such an updating procedure. BAC Reports has information for more than 25,000 different chemicals available but it is impossible to have all reports updated immediately. That is why it takes 3-5 days to update a report after an order is received.
Product Name:Imatinib mesylate / Gleevec
Synonyms:
  • Alpha-IMATINIB MESYLATE
  • Imatinib Mesilate
  • Gleevec
  • IMATINIB MESYLATE
  • Matinib mesylate
  • Imatinib Methanesulfonate
CAS#:220127-57-1

Skip to top


Ask Your Question

Imatinib mesylate / Gleevec (CAS 220127-57-1) Market Research Report 2016
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: